Umbilical Cord Lining Stem Cells (ULSC) in Patients With COVID-19 ARDS

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2020
ULSC-CV-01 is a clinical trial that comprises both Phase 1 and Phase 2a, which will be conducted sequentially. This trial will evaluate the safety and potential efficacy of allogeneic Umbilical Cord Lining Stem Cells (ULSC), which are a type of umbilical cord tissue derived mesenchymal stem cells (MSC), with intravenous (IV) administration in hospitalized patients with acute respiratory distress syndrome (ARDS) due to COVID-19.
Epistemonikos ID: 4439732598e0ec2c030da87d683412232845cbe0
First added on: Aug 01, 2020